Status:
UNKNOWN
Development of Intervention for Women After Gestational Diabetes or Pre-eclampsia
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Pre-Eclampsia
Gestational Diabetes
Eligibility:
FEMALE
18-50 years
Brief Summary
Our objectives in this qualitative exploratory study: * To explore the perspectives and preferences of women with preeclampsia and/or GDM history related to a potential health promotion program * To ...
Detailed Description
This study aims to explore experiences, views and concerns of women with history of preeclampsia and/or GDM and gain in-depth understanding of the factors that would motivate or deter adoption and adh...
Eligibility Criteria
Inclusion
- women:
- within 12 months of a live birth
- After a pregnancy where women were diagnosed with preeclampsia and/or GDM (diagnosed) within 12 months post-partum
- Between 18 and 50 years old
Exclusion
- \- We will exclude women with serious complications of preeclampsia and or/GDM as perinatal mortality or multi-organ failure.
Key Trial Info
Start Date :
January 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04716244
Start Date
January 20 2021
End Date
July 31 2025
Last Update
April 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Center
Jerusalem, Please Select An Option Below, Israel, 91120